Louisiana sues dialysis drug maker
BATON ROUGE, La. (AP) - Louisiana is suing drug maker Fresenius Medical Care North America and its nearly 100 Louisiana clinics over the use of two dialysis drugs - GranuFlo and NaturaLyte - that could contribute to fatal heart attacks.
The drugs have since been recalled by the federal government.
The lawsuit, filed in state district court in Baton Rouge by the state Attorney General's Office, says Fresenius violated Louisiana law in an effort to defraud dialysis clinics, physicians, the state and its residents.
Fresenius officials could not be reached for comment Friday.
The lawsuit seeks civil penalties of $5,000 per violation under Louisiana's Unfair Trade Practices and Consumer Protection Law. Louisiana is also asking the court to force Fresenius to pay back any profit made on the sale of GranuFlo.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
INVESTIGATIVE UNIT: Sheriff's office admits to mistake after not sending rape kit...
Tired of sifting through multiple mortgage company requests
Central residents tired of flooding; drainage clean-up to begin July 10
Woman accused in murder of molester takes plea deal
Area ice cream shop fires employees after tirade aimed at sheriff's deputies